Skip to content

Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy

Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06734598
Enrollment
120
Registered
2024-12-16
Start date
2024-12-01
Completion date
2026-02-01
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BOTOX, Head and Neck Cancer, Radiation Therapy Recipient, Trismus

Brief summary

Trismus is a common side effect in head and neck cancer patients after radiation therapy. This project aims to explore the therapeutic effect of Botulinum toxin (Botox) injection to the masticatory muscles in the above-mentioned patients. In this project, Botulinum toxin will be injected into the masticatory muscles (medial pterygoid and masticatory muscles), combined with oral rehabilitation exercises, to reduce the patient's masticatory muscle tension and spasm. Patient's mouth opening range, quality of life, trismus condition and pain will be evaluated to understand its efficacy.

Interventions

DRUGEcho-guided Botox injection

Echo-guided Botox injection to the masticatory muscles

PROCEDUREecho-guided normal saline injection

echo-guided normal saline injection

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged over 18 years old; 2. Head and neck cancer patients must have completed radiotherapy for at least 3 months; 3. Those whose mouth-opening distance is less than or equal to 3.5 cm (the functional cut-off point of trismus) and who have tightness or pain in the masticatory muscles; 4. Medical condition is stable;

Exclusion criteria

1. Those who have undergone surgery on their masticatory muscles; 2. Patients with obvious muscle atrophy or complete fibrosis of masticatory muscles ; 3. Those with tumor recurrence at the time of admission; 4. Those whose vital signs are unstable due to acute illness.

Design outcomes

Primary

MeasureTime frame
Maximal Incisal OpeningFrom enrollment to the end of treatment at 6 months

Countries

Taiwan

Contacts

Primary ContactDr. Chen
b00401020@ntu.edu.tw+88623123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026